Elise A Olsen MD

Professor of Dermatology and Medicine, Duke University

Summary

Dr. Elise Olsen is Professor of Dermatology and Hematologic Malignancies at Duke University Medical Center in Durham, NC. She trained in Internal Medicine at the University of North Carolina and in Dermatology at Duke University. She is the founder and Director of the Hair Disorders and the Cutaneous Lymphoma Research and Treatment Centers. She has been President of the International Society for Cutaneous Lymphoma, the United States Cutaneous Lymphoma Consortium (USCLC), the American Hair Research Society (AHRS) and the Southeastern Consortium for Dermatology. She is the first author on key trisociety international guideline papers on cutaneous lymphoma and founded the USCLC Registry for Cutaneous Lymphomas. She has published two textbooks on hair (Hair Disorders: Diagnosis and Treatment) and multiple papers on assessment techniques for pattern hair loss, alopecia areata. and cicatricial alopecia. She has received recognition by the International League of Dermatologic Societies for her work in hair loss and is the recipient of the David Whiting Research Award of the AHRS. She has been the PI on over 170 clinical trials. She is an honorary member of the American Academy of Dermatology and has been recognized as one of America's Top Doctors and America's Top Doctors for Cancer.

Duke University HospitalResidency, Dermatology, 1980 - 1983
University of North Carolina HospitalsInternship, Internal Medicine, 1978 - 1980
Baylor College of MedicineClass of 1978

America's Top Doctors for Cancer Castle Connolly, 2005-2021
CMS Meaningful Use Stage Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017

PubMed

European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus rec...
Rein Willemze, Chalid Assaf, Martine Bagot, Marie Beylot-Barry, Emilio Berti
The British Journal of Dermatology. 2025-11-18
1 citations
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.
Amrita Goyal, Daniel O'Leary, Bouthaina Dabaja, Wen-Kai Weng, Jasmine Zain
Journal of the American Academy of Dermatology. 2025-08-01
5 citations
Summation and recommendations for the safe and effective use of topical and oral minoxidil.
Elise A Olsen, Rodney Sinclair, Maria Hordinsky, Natasha A Mesinkovska, Neil Sadick
Journal of the American Academy of Dermatology. 2025-08-01

Journal Articles

Central Centrifugal Cicatricial Alopecia- What has been achieved, current clues for future research
Ogunleye TA, McMichael A, Olsen EA, African Skin and Hair Disorders, Dermatology Clinics, 1/1/2014
The efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma
Duvic M, Martin AG, Olsen EA, Fivenson DP, Prince HM, Leuk Lymphoma, 1/1/2013
Denileukin Diftitox for the Treatment of CD25 Low-Expression Mycosis Fungoides and Sezary Syndrome
Prince HM, Martin AG, Olsen EA, Fivenson DP, Duvic M, Leuk Lymphoma, 1/1/2013

Lectures

Hair Loss in Women
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
Pennsylvania Academy of Dermatology and Dermatologic Surgery 45th Annual Meeting
Pennsylvania Academy of Dermatology and Dermatologic Surgery, Bedford, Pennsylvania - 9/21/2012

Other